276 related articles for article (PubMed ID: 2826741)
1. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
[TBL] [Abstract][Full Text] [Related]
2. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
Springall DR; Ibrahim NB; Rode J; Sharpe MS; Bloom SR; Polak JM
J Pathol; 1986 Nov; 150(3):151-62. PubMed ID: 3027289
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
[TBL] [Abstract][Full Text] [Related]
4. Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma.
Hamid QA; Addis BJ; Springall DR; Ibrahim NB; Ghatei MA; Bloom SR; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1987; 411(2):185-92. PubMed ID: 3037770
[TBL] [Abstract][Full Text] [Related]
5. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
[TBL] [Abstract][Full Text] [Related]
7. Gastrin releasing peptide in human neuroendocrine tumours.
Bostwick DG; Bensch KG
J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
[TBL] [Abstract][Full Text] [Related]
8. Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours.
Suresh UR; Wilkes S; Hasleton PS
J Clin Pathol; 1991 Jul; 44(7):573-5. PubMed ID: 1713221
[TBL] [Abstract][Full Text] [Related]
9. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
10. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
[TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors.
Bostwick DG; Roth KA; Evans CJ; Barchas JD; Bensch KG
Am J Pathol; 1984 Nov; 117(2):195-200. PubMed ID: 6093543
[TBL] [Abstract][Full Text] [Related]
12. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
Mayall FG; Gibbs AR
J Pathol; 1991 May; 164(1):47-50. PubMed ID: 1647450
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody 123C3 in lung tumour classification. Immunohistology of 358 resected lung tumours.
Mooi WJ; Wagenaar SS; Schol D; Hilgers J
Mol Cell Probes; 1988 Mar; 2(1):31-7. PubMed ID: 2837665
[TBL] [Abstract][Full Text] [Related]
14. S-100 protein in human lung neuroendocrine neoplasms. Immunohistochemical study of 14 cases and review of the literature.
Barbareschi M; Mauri MF; Muscara M; Mauri FA; Lo Re V
Histol Histopathol; 1987 Apr; 2(2):185-92. PubMed ID: 2856552
[TBL] [Abstract][Full Text] [Related]
15. Carcinomas of the lung with neuroendocrine differentiation.
Carter D; Yesner R
Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
[TBL] [Abstract][Full Text] [Related]
16. Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
Leader M; Collins M; Patel J; Henry K
J Clin Pathol; 1986 Nov; 39(11):1186-92. PubMed ID: 3540015
[TBL] [Abstract][Full Text] [Related]
17. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
18. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
20. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
